Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-19-001016
Filing Date
2019-02-14
Accepted
2019-02-14 08:37:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 XENON PHARMACEUTICALS, INC. p19-0111sc13g.htm SC 13G 59517
  Complete submission text file 0000902664-19-001016.txt   60994
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88403 | Film No.: 19601066
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
venBio Select Advisor LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G